Reza Jahanshahi

Mr. Reza Jahanshahi

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2020 in OMEGA - Journal of Death and Dying
Verified
Journal Article
Closed access
PDF file
FMFarzaneh Safari Malak-Kolaei
Farzaneh Safari Malak-Kolaei
ASAkram Sanagoo
Akram Sanagoo
BPBagher Pahlavanzadeh
Bagher Pahlavanzadeh
FAForouzan Akrami
Forouzan Akrami
LJLeila Mahasti Jouybari
Leila Mahasti Jouybari
RJReza Jahanshahi
Reza Jahanshahi
This study aimed to determine the relationship between death and DNR attitudes among ICNs. This descriptive-analytical study was performed on 156 ICNs in 2018. All nurses were enrolled in the study; data collection instruments included Death Attitude Profile-Revised (DAP-R) and the DNR attitude questionnaires. The mean scores of DAP-R and DNR items were 150.89/ ± 23.59 and 91.82 ± 11.41, respectively. There was a significant relationship between death attitude and DNR attitude Famong ICNs. All dimensions of DAP-R significantly predicted attitude toward DNR (P < 0.05). Among those, “neutral acceptance” (1.17 [95% CI (0.68--1.65)] was the strongest predictor and “death avoidance” was the weakest predictor (0.36 [95% CI (0.09--0.62)]. There was a significant relationship between the ICNs' work experience and attitude toward DNR (p = 0.03). The findings can be used in formulation of the national guideline for DNR order.

29 September 2022 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
RJReza Jahanshahi
Reza Jahanshahi
ANAmirreza Nasirzadeh
Amirreza Nasirzadeh
MFMahan Farzan
Mahan Farzan
Jan DomaradzkiJan Domaradzki
Jan Domaradzki
LJLeila Mahasti Jouybari
Leila Mahasti Jouybari
SBSasan Bahramzadeh
Sasan Bahramzadeh
Background: Rare diseases are a new global health priority, requiring evidence-based estimates of the global prevalence of diseases to inform public policymakers and provide a serious challenge to the healthcare system that must not be ignored. The purpose of this study is to investigate Iranian future healthcare professionals' knowledge and opinions about rare diseases. Results: A total of 6838 students responded to the questionnaire. Nursing and medical students had the highest participation. Almost 85% of participants rated their knowledge about rare diseases as poor or insufficient. While nearly 70 percent of participants took courses about rare diseases at university. Finally, 72.7% of future healthcare professionals did not feel ready to take care of a patient with a rare disease. Conclusion: The present study has indicated a gap in Iranian medical students’ knowledge of rare diseases. The researchers believe that health science policymakers should make a joint effort to improve knowledge about rare diseases. Including courses with regard to rare diseases would be of benefit to future healthcare professionals.

21 January 2025 in Journal of Community Genetics
Verified
Journal Article
Closed access
PDF file
Jan DomaradzkiJan Domaradzki
Jan Domaradzki
RJReza Jahanshahi
Reza Jahanshahi
MWMarcin Piotr Walkowiak
Marcin Piotr Walkowiak
DWDariusz Walkowiak
Dariusz Walkowiak

1 October 2023 in Journal of Research Development in Nursing and Midwifery
Verified
Journal Article
Open access
PDF file
RJReza Jahanshahi
Reza Jahanshahi
FMFatemeh Mirzaei
Fatemeh Mirzaei
MAMohammad Hossein Askari
Mohammad Hossein Askari
NANafiseh Asgari
Nafiseh Asgari
SGShohreh Ghasemi
Shohreh Ghasemi
LJLeila Mahasti Jouybari
Leila Mahasti Jouybari
Background: Because of the numerous problems created by neurofibromatosis type 1, particular quality-of-life evaluation measures are quite significant. In Iran, general instruments are used to assess the quality of life of the target group. This study aimed to translate and examine the psychometrics of the Persian version of the Neurofibromatosis ...

1 October 2025 in Medical Sciences
Verified
Journal Article
Open access
PDF file
ANAmirreza Nasirzadeh
Amirreza Nasirzadeh
AGAmir Ghasemi
Amir Ghasemi
AAAlireza Afshari-Safavi
Alireza Afshari-Safavi
MNMohammad Ali Nahayati
Mohammad Ali Nahayati
RJReza Jahanshahi
Reza Jahanshahi
Faraidoon HaghdoostFaraidoon Haghdoost
Faraidoon Haghdoost
Background: Migraine is often not diagnosed or treated properly, despite being a common condition. The ID-migraine is a brief, self-administered test developed as a valuable tool for screening and diagnosing migraine in primary care settings. The objective of the present study was to produce a Persian translation of the original ID-migraine, perform cultural adaptation, and evaluate its validity. Methods: Consecutive patients who attended two neurology clinics for headache were enrolled in the study. Diagnoses were established by headache specialists and were compared with the Persian ID-migraine results. Results: Among the 657 participants included, 470 (71.5%) were clinically diagnosed with migraine, 120 (18.2%) with tension-type headache, and 40 (6.1%) with cluster headache. The validity attributes of the Persian ID-migraine were as follows: sensitivity, 0.96 (95% CI, 0.93–0.98); specificity, 0.46 (95% CI, 0.35–0.56); positive predictive value, 0.86 (95% CI, 0.82–0.89); negative predictive value, 0.76 (95% CI, 0.63–0.87), and a misclassification error of 14.9%. The questionnaire’s Kappa coefficient was 0.78. Conclusions: The Persian version of the ID-migraine questionnaire exhibited sufficient sensitivity and positive predictive value, along with an acceptable misclassification error. However, it demonstrated a deficient level of specificity and a considerably reduced negative predictive value.

11 December 2023 in Thalassemia Reports
Verified
Journal Article
Open access
PDF file
AAAily Aliasgharian
Aily Aliasgharian
HKHossein Karami
Hossein Karami
MZmohammad zahedi
mohammad zahedi
RJReza Jahanshahi
Reza Jahanshahi
HBHossein Bakhtiari-Dovvombaygi
Hossein Bakhtiari-Dovvombaygi
HDHadi Darvishi-Khezri
Hadi Darvishi-Khezri
Background and aim: We conducted a review to determine the efficacy of amlodipine alongside iron chelators on serum ferritin levels and liver T2-weighted magnetic resonance imaging (MRI T2*) in β-thalassemia patients. Methods: Systematic search was conducted in multiple databases, including Web of Science, PubMed, Scopus, Embase, Cochrane Library, ClinicalTrials.gov, the Iranian Registry of Clinical Trials (IRCT), ProQuest, OpenGrey, and Web of Science Conference Proceedings Citation Index. The search was closed in January 2023. Primary outcomes were comprised of liver MRI T2* (millisecond (msec)) and serum ferritin levels (ng/mL). Results: Seven studies (n = 227) were included in the study. The pooled Cohen’s d for serum ferritin was estimated at −0.46, 95% confidence interval (CI) −1.11 to 0.19 and p = 0.16 (I2 86.23%, p < 0.0001). The pooled mean difference for serum ferritin was −366.44 ng/mL, 95% CI −844.94 to 112.05, and p = 0.13 (I2 81.63%, p < 0.0001). After a meta-regression based on the length of using amlodipine, a coefficient for the mean difference was also −23.23 ng/mL and 95% CI −155.21 to 108.75. The coefficient obtained from a meta-regression as per the amlodipine dose at 5 mg/day than 2.5 to 5 mg/day anchored at −323.49 ng/mL and 95% CI −826.14 to 1473.12. A meta-regression according to the baseline values of serum ferritin discovered a coefficient of 1.25 ng/mL and 95% CI 0.15 to 2.35. Based on two included studies (n = 96), the overall Cohen’s d for liver MRI T2* was 2.069, 95% CI −0.896 to 5.035, and p = 0.17 (I2 96.31%, p< 0.0001). The synthesized mean difference for liver MRI T2* was 8.76 msec, 95% CI −4.16 to 21.67, and p = 0.18 (I2 98.38%, p < 0.000). Conclusion: At a very low level of evidence, probably using amlodipine at a dose of 2.5 to 5 mg a day, up to a year, alongside iron chelators slightly decreases serum ferritin levels in iron-overloaded thalassemia cases by nearly 366 ng/mL (23 ng/mL per month). The liver MRI T2* might also rise to 8.76 msec upon co-therapy with amlodipine.